Takumi Ito

5PUBLICATIONS
4CO-AUTHORS
Pharmaceutical delivery technologiesProteins and peptidesMolecular medicineMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 23, 2023
Protein degraders - from thalidomide to new PROTACs.

Takumi Ito

|Jul 07, 2022
Discovery of CRBN as a target of thalidomide: a breakthrough for progress in the development of protein degraders.

Junichi Yamamoto, Takumi Ito, Yuki Yamaguchi

|Nov 12, 2021
PLZF and its fusion proteins are pomalidomide-dependent CRBN neosubstrates.

Nobuyuki Shimizu, Tomoko Asatsuma-Okumura, Junichi Yamamoto

|Sep 22, 2020
ARID2 is a pomalidomide-dependent CRL4CRBN substrate in multiple myeloma cells.

Junichi Yamamoto, Tetsufumi Suwa, Yuki Murase

|Mar 06, 2020
Genome-wide screening reveals a role for subcellular localization of CRBN in the anti-myeloma activity of pomalidomide.

Shumpei Tateno, Midori Iida, Satoshi Fujii

Pageof 1

Frequent Collaborators

4 joint publications

Hiroshi Handa

2 joint publications

Tomoko Asatsuma-Okumura

1 joint publications

Satoshi Sakamoto

1 joint publications

Junichi Yamamoto